Madrigal Pharmaceuticals Swings to Q3 Earnings as Revenue Rises
Madrigal Pharmaceuticals reported a Q3 earnings swing and higher revenue.
Related stories
Ferrari CEO says all Luce EVs planned for 2027 are allocated
M impact | EQUITY | Nov 03, 2026, 02:03 PM UTC
Ferrari CEO: Entire Luce EV production planned for 2027 is allocated
Ferrari’s CEO said the entire production of its Luce EV planned for 2027 has been allocated.
M impact | EQUITY | Nov 03, 2026, 02:03 PM UTC
European session market picture: S&P 500 +0.16%, Nasdaq 100 +0.71%; EUR/USD +0.06%, WTI -1.97%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.16 percent, Nasdaq futures is up 0.71 percent, Dow futures is down 0.27 percent and Russell futures is up
M impact | EQUITY | Nov 03, 2026, 02:00 PM UTC
CVR Energy shares fall after stock offering tied to Marathon refinery deal
CVR Energy shares fell 2.5% in premarket trading after the company announced a stock offering tied to its Marathon refinery transaction.
M impact | EQUITY | Nov 03, 2026, 01:58 PM UTC
India Pesticides Q2 Consolidated Revenue INR 2,287.1 Million
M impact | EQUITY | Nov 03, 2026, 01:57 PM UTC
Apple shares fall as Wall Street futures diverge on US election day
Apple shares are falling while Wall Street futures are mixed.
M impact | EQUITY | Nov 03, 2026, 01:57 PM UTC